We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.87B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRLA
3651
DELISTED
TRULIA INC (DEL)
TRLA
$739K ﹤0.01%
21,126
+9,202
+77% +$349K
CYS
3652
DELISTED
CYS Investments Inc.
CYS
$735K ﹤0.01%
105,063
+53,178
+102% +$427K
SUB icon
3653
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$734K ﹤0.01%
6,912
-7,112
-51% -$756K
ISBC
3654
DELISTED
Investors Bancorp, Inc.
ISBC
$734K ﹤0.01%
74,859
+29,189
+64% +$270K
AUXL
3655
PUT
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$734K ﹤0.01%
36,700
+24,800
+208% +$468K
PRGS icon
3656
Progress Software
PRGS
$1.76B
$732K ﹤0.01%
29,257
-21,409
-42% -$554K
DOV icon
3657
PUT
Dover
DOV
$28.4B
$730K ﹤0.01%
11,338
-2,386
-17% -$146K
MGA icon
3658
PUT
Magna International
MGA
$18.8B
$730K ﹤0.01%
17,800
-5,000
-22% -$207K
LEA icon
3659
CALL
Lear
LEA
$8.18B
$728K ﹤0.01%
9,100
-3,700
-29% -$290K
PMC
3660
DELISTED
PharMerica Corporation
PMC
$728K ﹤0.01%
34,649
+7,980
+30% +$145K
BGG
3661
DELISTED
Briggs & Stratton Corp.
BGG
$727K ﹤0.01%
34,614
-32,310
-48% -$640K
GVA icon
3662
Granite Construction
GVA
$5.62B
$725K ﹤0.01%
21,342
-1,246
-6% -$39.2K
JKS
3663
PUT
JinkoSolar
JKS
$891M
$725K ﹤0.01%
25,000
+200
+0.8% +$5.38K
OTTR icon
3664
Otter Tail
OTTR
$3.94B
$723K ﹤0.01%
24,905
+3,906
+19% +$114K
SAM icon
3665
CALL
Boston Beer
SAM
$1.92B
$723K ﹤0.01%
3,000
-14,400
-83% -$3.46M
RPRX
3666
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$722K ﹤0.01%
40,100
-507,800
-93% -$9.59M
YPF icon
3667
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$719K ﹤0.01%
22,481
+1,428
+7% +$36.6K
CLMT icon
3668
PUT
Calumet Specialty Products
CLMT
$3.44B
$718K ﹤0.01%
27,600
-1,800
-6% -$50.3K
FLS icon
3669
CALL
Flowserve
FLS
$10.2B
$718K ﹤0.01%
9,200
-45,200
-83% -$3.13M
DOC icon
3670
CALL
Healthpeak Properties
DOC
$14.8B
$717K ﹤0.01%
21,850
-49,740
-69% -$1.77M
PDT
3671
John Hancock Premium Dividend Fund
PDT
$626M
$716K ﹤0.01%
65,076
+27,448
+73% +$328K
STLD icon
3672
PUT
Steel Dynamics
STLD
$37.6B
$716K ﹤0.01%
37,700
+3,700
+11% +$67.8K
BLOX
3673
CALL
DELISTED
Infoblox Inc
BLOX
$716K ﹤0.01%
21,700
-60,400
-74% -$2.36M
OREX
3674
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
$716K ﹤0.01%
14,320
+3,250
+29% +$183K
VMI icon
3675
CALL
Valmont Industries
VMI
$9.53B
$715K ﹤0.01%
4,800
+2,200
+85% +$311K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.